Literature DB >> 25279441

C-Reactive Protein at Discharge, Diabetes Mellitus and ≥ 1 Hospitalization During Previous Year Predict Early Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Ernesto Crisafulli1, Antoni Torres, Arturo Huerta, Raúl Méndez, Mónica Guerrero, Raquel Martinez, Adamantia Liapikou, Néstor Soler, Sanjay Sethi, Rosario Menéndez.   

Abstract

Recurrent hospitalizations in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients have clinical and economic consequences; particularly those readmitted soon after discharge. The aim of our observational study was to determine predictors of early readmission to hospital (30 days from discharge). Prospective data on 125 hospitalized AECOPD patients were collected over a 30-month period at two Spanish university hospitals. Based on readmission after discharge, patients were divided into non-readmitted (n = 96) and readmitted (n = 29). Measures of serum inflammatory biomarkers were recorded on admission to hospital, at day 3 and at discharge; data on clinical, laboratory, microbiological and severity features were also recorded. In a multivariate model, C-reactive protein (CRP) at discharge ≥ 7.6 mg/L, presence of diabetes and ≥ 1 hospitalization for AECOPD during previous year were significant risk factors for predicting readmission. Presence of all 3 risk factors perfectly identified the readmitted patients (positive and negative predictive values of 1.000; 95% CI, 1.00-1.00). A combination of 3 readily available clinical and biochemical parameters is accurate in identifying hospitalized AECOPD patients at risk for early readmission.

Entities:  

Keywords:  acute exacerbation; chronic obstructive pulmonary disease; inflammatory response; predictors; readmission

Mesh:

Substances:

Year:  2014        PMID: 25279441     DOI: 10.3109/15412555.2014.933954

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  9 in total

1.  [Outcome predictors for COPD patients hospitalized for acute exacerbation].

Authors:  M Spielmanns; F Axer; C Nell; A R Koczulla; T Boeselt; F Magnet; J H Storre; W Windisch
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-01-02       Impact factor: 0.840

Review 2.  Risk factors of adverse health outcomes after hospital discharge modifiable by clinical pharmacist interventions: a review with a systematic approach.

Authors:  Benedict Morath; Tanja Mayer; Alexander Francesco Josef Send; Torsten Hoppe-Tichy; Walter Emil Haefeli; Hanna Marita Seidling
Journal:  Br J Clin Pharmacol       Date:  2017-06-14       Impact factor: 4.335

Review 3.  Acute exacerbations of COPD: risk factors for failure and relapse.

Authors:  Marco Mantero; Paola Rogliani; Marta Di Pasquale; Eva Polverino; Ernesto Crisafulli; Monica Guerrero; Andrea Gramegna; Mario Cazzola; Francesco Blasi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-09-08

4.  Circulating syndecan-1 as a novel biomarker relates to lung function, systemic inflammation, and exacerbation in COPD.

Authors:  Diandian Li; Yanqiu Wu; Shujin Guo; Jiangyue Qin; Mei Feng; Yunfei An; Junlong Zhang; Yanping Li; Shuguang Xiong; Hui Zhou; Qianglin Zeng; Lei Chen; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-08-28

Review 5.  Prognostic risk factors for moderate-to-severe exacerbations in patients with chronic obstructive pulmonary disease: a systematic literature review.

Authors:  John R Hurst; MeiLan K Han; Barinder Singh; Sakshi Sharma; Gagandeep Kaur; Enrico de Nigris; Ulf Holmgren; Mohd Kashif Siddiqui
Journal:  Respir Res       Date:  2022-08-23

6.  T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients.

Authors:  Cheng Wang; Hong Wang; Luming Dai; Jianqing Zhang; Lizhou Fang; Ling Liu; Weiping Fu; Dang Tang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-05-27

7.  Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study.

Authors:  Mónica Guerrero; Ernesto Crisafulli; Adamantia Liapikou; Arturo Huerta; Albert Gabarrús; Alfredo Chetta; Nestor Soler; Antoni Torres
Journal:  PLoS One       Date:  2016-03-04       Impact factor: 3.240

8.  Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China.

Authors:  Lina Sun; Yahong Chen; Rui Wu; Ming Lu; Wanzhen Yao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-20

Review 9.  Management of severe acute exacerbations of COPD: an updated narrative review.

Authors:  Ernesto Crisafulli; Enric Barbeta; Antonella Ielpo; Antoni Torres
Journal:  Multidiscip Respir Med       Date:  2018-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.